Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004654426> ?p ?o ?g. }
- W2004654426 endingPage "6477" @default.
- W2004654426 startingPage "6471" @default.
- W2004654426 abstract "The discovery of a novel series of potent and selective T-type calcium channel antagonists is reported. Initial optimization of high-throughput screening leads afforded a 1,4-substituted piperidine amide 6 with good potency and limited selectivity over hERG and L-type channels and other off-target activities. Further SAR on reducing the basicity of the piperidine and introducing polarity led to the discovery of 3-axial fluoropiperidine 30 with a significantly improved selectivity profile. Compound 30 showed good oral bioavailability and brain penetration across species. In a rat genetic model of absence epilepsy, compound 30 demonstrated a robust reduction in the number and duration of seizures at 33 nM plasma concentration, with no cardiovascular effects at up to 5.6 μM. Compound 30 also showed good efficacy in rodent models of essential tremor and Parkinson’s disease. Compound 30 thus demonstrates a wide margin between CNS and peripheral effects and is a useful tool for probing the effects of T-type calcium channel inhibition." @default.
- W2004654426 created "2016-06-24" @default.
- W2004654426 creator A5000572318 @default.
- W2004654426 creator A5001580477 @default.
- W2004654426 creator A5008884847 @default.
- W2004654426 creator A5014133544 @default.
- W2004654426 creator A5017950194 @default.
- W2004654426 creator A5020633551 @default.
- W2004654426 creator A5024772047 @default.
- W2004654426 creator A5025029227 @default.
- W2004654426 creator A5031350782 @default.
- W2004654426 creator A5034478882 @default.
- W2004654426 creator A5036115724 @default.
- W2004654426 creator A5041384227 @default.
- W2004654426 creator A5043813948 @default.
- W2004654426 creator A5051825577 @default.
- W2004654426 creator A5052664150 @default.
- W2004654426 creator A5057602614 @default.
- W2004654426 creator A5060483072 @default.
- W2004654426 creator A5063860453 @default.
- W2004654426 creator A5064543248 @default.
- W2004654426 creator A5065904291 @default.
- W2004654426 creator A5068636357 @default.
- W2004654426 creator A5073915074 @default.
- W2004654426 creator A5074066213 @default.
- W2004654426 creator A5074296141 @default.
- W2004654426 creator A5074329850 @default.
- W2004654426 creator A5074794226 @default.
- W2004654426 creator A5078594805 @default.
- W2004654426 creator A5084126298 @default.
- W2004654426 creator A5085972667 @default.
- W2004654426 creator A5087832273 @default.
- W2004654426 creator A5088871392 @default.
- W2004654426 creator A5089360429 @default.
- W2004654426 date "2008-09-26" @default.
- W2004654426 modified "2023-10-11" @default.
- W2004654426 title "Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium Channels" @default.
- W2004654426 cites W1505710118 @default.
- W2004654426 cites W1845250825 @default.
- W2004654426 cites W1963641716 @default.
- W2004654426 cites W1974758589 @default.
- W2004654426 cites W1979770529 @default.
- W2004654426 cites W1986279601 @default.
- W2004654426 cites W1993142627 @default.
- W2004654426 cites W1994413077 @default.
- W2004654426 cites W2001905701 @default.
- W2004654426 cites W2019707735 @default.
- W2004654426 cites W2019976015 @default.
- W2004654426 cites W2020004369 @default.
- W2004654426 cites W2020345477 @default.
- W2004654426 cites W2022864187 @default.
- W2004654426 cites W2033792938 @default.
- W2004654426 cites W2043019593 @default.
- W2004654426 cites W2048922444 @default.
- W2004654426 cites W2061186047 @default.
- W2004654426 cites W2061349012 @default.
- W2004654426 cites W2065214055 @default.
- W2004654426 cites W2066267636 @default.
- W2004654426 cites W2076891371 @default.
- W2004654426 cites W2078205120 @default.
- W2004654426 cites W2083848896 @default.
- W2004654426 cites W2083866023 @default.
- W2004654426 cites W2084218548 @default.
- W2004654426 cites W2084255998 @default.
- W2004654426 cites W2107763854 @default.
- W2004654426 cites W2112520390 @default.
- W2004654426 cites W2112923968 @default.
- W2004654426 cites W2117047364 @default.
- W2004654426 cites W2118076811 @default.
- W2004654426 cites W2124698022 @default.
- W2004654426 cites W2126437964 @default.
- W2004654426 cites W2130267750 @default.
- W2004654426 cites W2134670392 @default.
- W2004654426 cites W2135194733 @default.
- W2004654426 cites W2137024142 @default.
- W2004654426 cites W2152641996 @default.
- W2004654426 cites W2153391036 @default.
- W2004654426 cites W2157384478 @default.
- W2004654426 cites W2160342674 @default.
- W2004654426 cites W2187230393 @default.
- W2004654426 cites W2912991414 @default.
- W2004654426 cites W2951670509 @default.
- W2004654426 doi "https://doi.org/10.1021/jm800830n" @default.
- W2004654426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18817368" @default.
- W2004654426 hasPublicationYear "2008" @default.
- W2004654426 type Work @default.
- W2004654426 sameAs 2004654426 @default.
- W2004654426 citedByCount "87" @default.
- W2004654426 countsByYear W20046544262012 @default.
- W2004654426 countsByYear W20046544262013 @default.
- W2004654426 countsByYear W20046544262014 @default.
- W2004654426 countsByYear W20046544262015 @default.
- W2004654426 countsByYear W20046544262016 @default.
- W2004654426 countsByYear W20046544262017 @default.
- W2004654426 countsByYear W20046544262018 @default.
- W2004654426 countsByYear W20046544262019 @default.
- W2004654426 countsByYear W20046544262020 @default.
- W2004654426 countsByYear W20046544262021 @default.